Nightingale Health

To the best of our knowledge, this is the company’s most valuable commercial contract to date and demonstrates once again the company’s ability to carry out large-scale research projects.

The service agreement opens a new distribution channel to the Caribbean and the British Crown Dependencies.

Numerous small contracts support our growth forecasts.

The company is investing fully in sales to achieve its growth targets.

24:54

During the second half of the financial year, Nightingale Health's revenue grew to 3.09 MEUR.

The Eloisa project opens the door towards public healthcare.

We estimate that H2 revenue grew by 47%, driven by research projects and the Terveystalo partnership.

The commercial agreement was preceded by three completed pilots.